Market Place
Sourcing Support
Blaze Bioscience Announces FDA Has Granted Fast Track Designation to BLZ-100
07 Apr 2020 //
BUSINESSWIRE
Blaze Bioscience Announces the Publication of Phase 1 Clinical Trial Results
09 May 2019 //
BUSINESSWIRE
Blaze Bio posts phase 1 data for cancer-illuminating `tumor paint`
09 May 2019 //
FIERCE BIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.